fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Tecentriq approved by European Commission as a first-line monotherapy treatment for people with a type of metastatic NSCLC – Roche

Written by | 19 May 2021

Roche has announced that the European Commission has approved Tecentriq (atezolizumab) as a first-line (initial) treatment for adults with metastatic non-small cell lung cancer (NSCLC) whose tumours have… read more.

How fasting diets could harm future generations

Written by | 19 May 2021

Fasting diets have risen in popularity in recent years, however little is known about the long-term impact of these diets, particularly for future generations. New research, published today… read more.

Choosing and using ivermectin for covid-19 in India

Written by | 19 May 2021

Interview and article by Christine Clark. In the Northern in Indian state of Uttar Pradesh, ivermectin has been in use for treatment and prophylaxis of covid-19 since August… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.